期刊論文| 1. | Beyer, I.、Mets, T.、Bautmans, I.(2012)。Chronic low-grade inflammation and age-related sarcopenia。Current Opinion in Clinical Nutrition and Metabolic Care，15(1)，12-22。   |
| 2. | European Association for the Study of the Liver(2019)。EASL Clinical Practice Guidelines on nutrition in chronic liver disease。J Hepatol，70，172-193。 |
| 3. | Montano-Loza, A. J.、Meza-Junco, J.、Baracos, V. E.(2014)。Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation。Liver Transpl，20，640-648。 |
| 4. | Kamo, N.、Kaido, T.、Hamaguchi, Y.(2019)。Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation。Clin Nutr，38，2202-2209。 |
| 5. | Montano-Loza, A. J.、Duarte-Rojo, A.、Meza-Junco, J.(2015)。Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis。Clin Transl Gastroenterol，6。 |
| 6. | DiMartini, A.、Cruz, R. J. Jr.、Dew, M. A.(2013)。Muscle mass predicts outcomes following liver transplantation。Liver Transpl，19，1172-1180。 |
| 7. | Montano-Loza, A. J.、Meza-Junco, J.、Prado, C. M.(2012)。Muscle wasting is associated with mortality in patients with cirrhosis。Clin Gastroenterol Hepatol，10，166-173。 |
| 8. | Bhanji, R. A.、Moctezuma-Velazquez, C.、Duarte-Rojo, A.(2018)。Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis。Hepatol International，12，377-386。 |
| 9. | Ha, Y.、Kim, D.、Han, S.(2018)。Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function。Cancer Res Treat，50，843-851。 |
| 10. | Meza-Junco, J.、Montano-Loza, A. J.、Baracos, V. E.(2013)。Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma。J Clin Gastroenterol，47，861-870。 |
| 11. | Ebadi, M.、Tandon, P.、Moctezuma-Velazquez, C.(2018)。Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis。J Hepatol，69，608-616。 |
| 12. | van Vugt, J. L. A.、Alferink, L. J. M.、Buettner, S.(2018)。A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort。J Hepatol，68，707-714。 |
| 13. | Drummond, M. J.、Dreyer, H. C.、Fry, C. S.(2009)。Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling。J Appl Physiol，106，1374-1384。 |
| 14. | Frost, R. A.、Lang, C. H.(2012)。Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle。Endocrinol Metab Clin North Am，41，297-322。 |
| 15. | Garcia, P. S.、Cabbabe, A.、Kambadur, R.(2010)。Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting。Anesth Analg，111，707-709。 |
| 16. | Morrison, W. L.、Bouchier, I. A.、Gibson, J. N.(1990)。Skeletal muscle and whole-body protein turnover in cirrhosis。Clin Sci，78，613-619。 |
| 17. | Okuda, H.、Shiratori, K.(2007)。Long-term nutritional assessment and quality of life in patients with cirrhosis taking a late evening snack。J Gastroenterol，42，186-187。 |
| 18. | Campillo, B.、Bories, P. N.、Pornin, B.(1997)。Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis。Nutrition，13，613-621。 |
| 19. | Shen, W.、Punyanitya, M.、Wang, Z.(2004)。Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image。J Appl Physiol，97，2333-2338。 |
| 20. | Sinclair, M.、Grossmann, M.、Hoermann, R.(2016)。Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial。J Hepatol，65，906-913。 |
| 21. | Picardi, A.、de Oliveira, A. C.、Muguerza, B.(1997)。Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis。J Hepat，26，191-202。 |
| 22. | Dasarathy, J.、Alkhouri, N.、Dasarathy, S.(2011)。Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature。Liver Int，31，1250-1258。 |
| 23. | Kumar, A.、Davuluri, G.、Silva, R. N. E.(2017)。Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis。Hepatology，65，2045-2058。 |
| 24. | Tsien, C.、Shah, S. N.、McCullough, A. J.(2013)。Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent。Eur J Gastroenterol Hepatol，25，85-93。 |
| 25. | Bergerson, J. T.、Lee, J. G.、Furlan, A.(2015)。Liver transplantation arrests and reverses muscle wasting。Clin Transplant，29，216-221。 |
| 26. | Tsien, C.、Garber, A.、Narayanan, A.(2014)。Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation。J Gastroenterology Hepatology，29，1250-1257。 |